The pharmaceutical industry has been slow in adopting digital marketing solutions. It relies on in-person visits by medical representatives, which is time-consuming, costly and inefficient.
While other industries leverage advanced digital tools, pharma marketing remains fragmented due to strict regulations and scattered platforms.
Doceree is changing this with its AI-powered platform designed to help pharma brands connect with doctors in a seamless, targeted, and data-driven manner.
Espyian, Doceree’s proprietary AI-powered platform, analyses physician behaviour to deliver personalised, speciality-specific messages. This ensures that healthcare professionals receive relevant information at the right time, improving engagement and optimizing marketing outcomes for pharma brands.
Keep reading to discover how Doceree is making pharma marketing smarter, more efficient, and results-driven.
Doceree: Connecting pharma brands with doctors using AI
Doceree is a global leader in healthcare marketing, connecting pharmaceutical brands with healthcare professionals (HCPs) using cutting-edge technology. It employs tools like:
Demand-side Platform (DSP):
This helps pharma brands plan, manage, and buy digital ad spaces efficiently.
Supply-side Platform (SSP):
Allows websites or platforms targeting HCPs to sell their ad spaces to the right advertisers.
Ad Server:
Ensures the right ads are shown to the right audience at the right time.
Data Management Platform (DMP):
Collects and analyses data to enable precise targeting and personalised communication.
How does Doceree work?
Doceree’s platform combines advanced, patented technology with real-time, data-driven messaging to create impactful HCP engagements:
Identity resolution
Its proprietary technology enables precision targeting using the largest Point-of-Care (POC) identity graph of authenticated HCPs in a GDPR– and PHI-compliant manner (to ensure data privacy and security in healthcare marketing).
Real-time analytics
Comprehensive reporting tools allow brands to plan, activate, measure, and analyse omni-channel campaigns efficiently.
Cookie-free targeting
Doceree ensures high accuracy in reaching HCPs without relying on third-party cookies, ensuring privacy compliance.
Seamless integration
The platform connects the healthcare ecosystem with advanced data and technology for better decision-making and patient outcomes.
Global presence
Operating across 4 continents and 22 markets, Doceree has established its footprint in North America, Europe, the Middle East, Africa, and Asia-Pacific. The platform’s goal is to redefine HCP-patient conversations by using patented, responsive technology.
Its HIPAA-certified platform ensures compliance with global privacy and data security standards, making it the largest physician-only programmatic marketing network.
Founders and leadership
Doceree was founded in 2019 by Harshit Jain and Daleep Manhas in New-Jersey. It was started to address the problem of rising healthcare costs and bring efficiency and effectiveness in pharma-doctor relationships.
Under Harshit Jain’s leadership, the company has transformed healthcare marketing, becoming a trusted partner for pharmaceutical brands to boost their digital engagement with HCPs.
Funding and valuation
Doceree has raised a total of $64.8M in funding over six rounds, beginning its journey with the first round on May 12, 2020. The company’s innovative approach and market potential have consistently attracted investor interest. Its latest valuation reflects its strong position in the industry.
Success stories: Doceree’s proven impact
Doceree has consistently demonstrated its ability to transform healthcare marketing and drive measurable results for its partners. Here are some notable success stories:
RSV vaccine campaign:
Through niche targeting with ICD & CPT codes, the campaign generated 11,000 RSV vaccine orders in just one month, effectively boosting HCP engagement and awareness.
Vaccine brand success:
A vaccine brand achieved over 4,000 additional doses ordered using Doceree’s advanced targeting capabilities.
ADPKD treatment:
A campaign for an FDA-approved treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD) led to a 445% increase in website traffic, showcasing the power of targeted digital engagement.
Cancer treatment campaign:
By adopting Account-Based Marketing (ABM), a cancer treatment campaign experienced 436% growth in landing page traffic, significantly expanding its reach to relevant HCPs.
Impact on healthcare costs
One of Doceree’s long-term goals is to reduce healthcare costs by introducing efficiency in pharma marketing.
“We believe, by introducing effectiveness and efficiency in pharma marketing, Doceree can reduce costs by about 10 percent, which would eventually reflect upon the pricing of drugs.”
– Harshit Jain, CEO and Founder, Doceree, said in an interview.
This vision aligns with Doceree’s mission to improve physician engagement while contributing to a more affordable and accessible healthcare system.
Looking ahead
Doceree is an excellent example of how innovative technology can change industries by addressing long-standing inefficiencies. Its advanced point-of-care solutions and targeting strategies empower pharma brands to overcome challenges, increase engagement, and drive impactful results.
In the short term, the company aims to become a primary revenue source for doctor-only digital platforms. It also plans to explore potential acquisitions to further strengthen its position as a leader in programmatic physician marketing.
With plans to expand its market presence, it’ll be interesting to see how Doceree will further revolutionise the pharma space.
-By Rinkle Dudhani and the AHT Team
